Fibrogenesis is part of a normal protective response to tissue injury that can become irreversible and progressive, leading to fatal diseases.
Most patients with chronic obstructive pulmonary disease (COPD) have at least one additional, clinically relevant chronic disease. Those with the most severe airflow obstruction will die from respiratory failure, but most patients with COPD die from non-respiratory disorders, particularly cardiovascular diseases and cancer.
COPD is a common, preventable, and treatable disease, but extensive under-diagnosis and misdiagnosis leads to patients receiving no treatment or incorrect treatment.
The Global Burden of Disease Study 2017 identified that a country’s sociodemographic index was a key factor affecting mortality and loss of health from respiratory diseases.
COPD is the elephant in the room for many patients with CVDs.
Los próximos 3, 4 y 5 de mayo tendrán lugar el VII Simposium Internacional de la EPOC y Tabaco y el XVII Simposium Internacional sobre prevención y tratamiento del tabaquismo.
Àlvar Agustí ha participado en este evento como miembro del comité científico de la reunión, resaltando la importancia de “pasar de una medicina reactiva a una medicina predictiva…»
It is now well established that there is a range of lung function tralectories throughout the life course.
Approximately 25% and 65% of patients hospitalized for an ECOPD die within 1 and 5 years, respectively.
The Global Burden of Disease Study 2017 identified that a country’s sociodemographic index was a key factor affecting mortality and loss of health from respiratory diseases.
